Cargando…

A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States

In the United States, meningococcal serogroup B (MenB) vaccination is recommended for 16–23-year-olds based on shared clinical decision-making. We estimated series completion among individuals initiating MenB vaccination for the 2 available vaccines: MenB 4-component (MenB-4C, doses at 0 and ≥1 mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Packnett, Elizabeth R., Zimmerman, Nicole M., Kim, Gilwan, Novy, Patricia, Morgan, Laura C., Chime, Nnenna, Ghaswalla, Parinaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Vaccine Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920016/ https://www.ncbi.nlm.nih.gov/pubmed/35086118 http://dx.doi.org/10.1097/INF.0000000000003455

Ejemplares similares

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

2278. Maternal Immunization Rates With Tetanus–Diphtheria–Acellular Pertussis and Influenza Vaccines in the United States: A Retrospective Claims Database Analysis
por: Ghaswalla, Parinaz, et al.
Publicado: (2018)

Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model
por: Vianzon, Vianca, et al.
Publicado: (2017)

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
por: Tejedor, Juan Carlos, et al.
Publicado: (2016)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study
por: Baccarini, Carmen I., et al.
Publicado: (2020)

Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US
por: Ghaswalla, Parinaz K., et al.
Publicado: (2022)

26. Factors Associated with Meningococcal Vaccination among Patients with Newly Diagnosed High-Risk Conditions
por: Ghaswalla, Parinaz, et al.
Publicado: (2020)

Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States
por: Marshall, Gary S, et al.
Publicado: (2021)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis
por: Ghaswalla, Parinaz K., et al.
Publicado: (2018)

Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination
por: Levine, Min Z., et al.
Publicado: (2016)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Meningococcal serogroups and surveillance: a systematic review and survey
por: Peterson, Meagan E, et al.
Publicado: (2019)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
por: Lingappa, Jairam R., et al.
Publicado: (2003)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

Meningococcal serogroup B disease in Turkey: A guess or reality?
por: Bakir, Mustafa
Publicado: (2014)

Neisseria cinerea Expresses a Functional Factor H Binding Protein Which Is Recognized by Immune Responses Elicited by Meningococcal Vaccines
por: Lavender, Hayley, et al.
Publicado: (2017)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Folaranmi, Temitope, et al.
Publicado: (2015)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
por: Martinelli, Domenico, et al.
Publicado: (2015)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
por: Petersen, Karin Dam, et al.
Publicado: (2011)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Characterization of T-Cell Responses to Conserved Regions of the HIV-1 Proteome in BALB/c Mice
por: Ondondo, Beatrice, et al.
Publicado: (2014)

Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
por: Rossi, Omar, et al.
Publicado: (2016)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ljt42634ikb47fjpf08nnbr86